指南与共识肝病

NAFLD-NASH临床试验中饮食与运动标准化:Liver Forum建议

Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum.
指南 / 共识 · J Hepatol · 2020-04-27

生活方式调整是NAFLD/NASH治疗基础,但临床试验缺乏系统评估饮食运动影响的方法。Liver Forum标准治疗工作组综述现有数据,识别障碍,提出标准化评估方法,以助解析生活方式改变对I-IV期试验结局的影响。

要点

  • NAFLD/NASH试验需系统评估生活方式改变对结局的影响。
  • 目前缺乏量化生活方式变量的标准化方法。
  • 建议统一饮食运动评估以利跨研究比较。

核心结论

  • 需标准化饮食与运动评估以解释NAFLD/NASH临床试验结局。

研究设计与样本

  • Liver Forum标准治疗工作组总结,综述现有临床数据并提出建议。

主要发现

  • 缺乏系统方法识别和评估生活方式改变对试验结局的影响。
  • 生活方式变量量化方法存在不确定性,影响跨研究比较。

临床怎么用

  • 试验中应采用统一方法评估饮食和运动,以解读药物干预效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lifestyle modification is the foundation of treatment recommendations for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The design of clinical trials in NASH may be impeded by the lack of a systematic approach to identify and evaluate how lifestyle changes and/or modifications influence clinical trial outcomes and associated endpoints. Furthermore, there are additional uncertainties regarding the methods that can be utilised to better characterise and quantify lifestyle variables - which can influence disease activity and alter trial endpoints - to allow for comparisons of trial outcomes across different phases of research and/or within drug-classes. This summary by the Liver Forum's Standard of Care Working Group reviews currently available clinical data, identifies the barriers and challenges associated with the standard of care in NAFLD/NASH clinical trials, defines available assessments of lifestyle changes, and proposes approaches to better understand and define the influence of diet and exercise on NASH treatment in the context of different pharmacologic interventions. The ultimate objective is to propose tangible solutions which enable investigators, sponsors, and regulatory authorities to meaningfully interpret clinical trial outcomes and the impact of lifestyle modification on such outcomes as they pertain to phase I-IV clinical trials.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Glass O, Filozof C, Noureddin M, et al. Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum. J Hepatol. 2020. PMID: 32353483. doi:10.1016/j.jhep.2020.04.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。